| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President | Chief Executive Officer
1 company
Novak Rodger is a President at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $31.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2020 | CRSP Crispr Therapeutics AG | President | Sell | 50,000 | $70.20 | $3,510,020.16 | -3.2% | |
| May 19, 2020 | CRSP Crispr Therapeutics AG | President | Sell | 50,000 | $65.00 | $3,250,000.00 | -5.9% | |
| Nov 19, 2019 | CRSP Crispr Therapeutics AG | President | Sale+OE | 33,618 | $70.00 | $2,353,260.00 | -100% | |
| Jul 10, 2019 | CRSP Crispr Therapeutics AG | President | Sell | 50,000 | $50.00 | $2,500,065.00 | -5.6% | |
| Jun 10, 2019 | CRSP Crispr Therapeutics AG | President | Sell | 50,000 | $45.00 | $2,250,000.00 | -5.3% | |
| Mar 4, 2019 | CRSP Crispr Therapeutics AG | President | Sell | 85,220 | $40.40 | $3,443,036.71 | -2.1% | |
| Feb 25, 2019 | CRSP Crispr Therapeutics AG | President | Sell | 14,780 | $40.00 | $591,232.52 | -1.4% | |
| Jan 9, 2019 | CRSP Crispr Therapeutics AG | President | Sell | 100,000 | $35.02 | $3,502,384.80 | -4.4% | |
| May 17, 2018 | CRSP Crispr Therapeutics AG | President | Sale+OE | 75,000 | $60.00 | $4,500,000.00 | -6.1% | |
| Sep 5, 2017 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 18,470 | $20.76 | $383,393.19 | -0.8% |